a biotech stock is reportedly outperforming major pharmaceutical companies, including lilly, merck, and pfizer, in 2026. the stock in question appears to be moderna, which has seen significant gains, including a 14% increase in one day. some outlets suggest moderna's strong performance may continue, while others consider whether it is still a good time to buy the stock.